- About Us
- Contact Us
Discover Targets, signatures and answers
Almac’s proprietary discovery arrays have been developed to provide the optimal platform for biomarker discovery and development across multiple disease areas (Xcel™ array) and specific disease areas (DSA®).
Almac provides access to these platforms to its partners in Pharma, Biotech and Academia as part of its biomarker partnering solutions.
These innovative tools are an important asset to Almac’s drive to enable personalised medicine.